(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. - Wikidata - wikimedia - TriplyDB

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

http://www.wikidata.org/entity/Q39919495

about

Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay The Warburg effect: 80 years on FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials.Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy.FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable Evaluation of cancer treatment in the abdomen: Trends and advances.Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of T-lymphoblastic lymphoma patients.State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".CT, MRI, and 18F-FDG PET/CT Findings in Untreated Pulmonary and Hepatic B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Over a Five-Year Period: A Case Report.Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma.FDG-PET imaging in hematological malignancies A new dimension of FDG-PET interpretation: assessment of tumor biology.Impact of FDG-PET/CT in the management of lymphoma.18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review.Advances in oncologic imaging: update on 5 common cancers.FDG PET/CT in children and adolescents with lymphoma.Nodal marginal zone lymphoma.PET/CT in malignant lymphoma: basic information, clinical application, and proposal.When should FDG-PET be used in the modern management of lymphoma?FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis.Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study.Current role of FDG PET/CT in lymphoma.Theranostic nanoparticles for cancer and cardiovascular applications.Role of PET in lymphoma.Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.FDG-PET/CT pitfalls in oncological head and neck imaging.Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.

P2860

Q26745461-CA4B29C6-ADE3-4CF3-B896-865A3376C718 Q26752284-21CC0655-5C25-478B-9CBD-791B23EAB382 Q26781731-56079508-3CE1-498A-9D77-E5D005F710E1 Q26801870-2EE9D76B-6C65-47F5-886B-321F1142EF67 Q26852398-156C99C0-850E-4F26-85AE-FE4F09729DDB Q26996477-6558AB84-0792-4A05-8F44-ABE1A22A19FD Q26996650-D48F469B-014E-48AF-9D40-479A4502693A Q27015708-DC283E16-85B4-4FE5-8B26-7480E93841B5 Q28076125-A8C16B26-763E-43F2-BE1F-A76AC343C4E4 Q33642244-41B0AC80-AAD6-4B3B-A1F2-60D77F6F89F5 Q33820910-5884163F-9114-4F53-AFDA-C5CDEF388BD0 Q34663865-E3438D6C-5159-46E4-80C8-D2AB8D5A728C Q34908079-7FB3F38E-AD6C-469C-8FB1-7E2BF6C331C8 Q35828077-884357CB-AF88-4AD5-948A-D187C3159345 Q36435559-9234EA72-2FFE-4519-B20D-2EC9D4E32F84 Q36686045-B0765B01-35F3-4B73-B4C6-8E6A5CB09DE7 Q36832118-2D0F0771-A344-49A6-BCCC-D384C12234BD Q37107545-6F40DAA6-9685-47A5-A5AD-275BF51F8BBA Q37144956-2285F4D0-90FD-4D21-B3BE-E18E38818D9E Q37205488-BE3AE89D-B443-41AD-9A4C-75F27F934889 Q37240835-32D0ADC2-ED3B-4A7E-8F16-41D2BA131521 Q37432055-245780B0-2809-4F73-B200-D804D5932311 Q37632114-81997DB7-09E4-40C0-9411-E5E8096F5789 Q37827752-6C78D098-E6E4-4780-9E63-960B8EDEC589 Q37950857-DD3F0FBF-12DB-4BB1-A051-57B8D3AAC581 Q38035960-E684C3EC-8C0F-49F5-A3AE-119FB55948A8 Q38052458-7D50EFC7-42A3-4CE4-8410-CD5D9F09027D Q38092706-88D2F4DA-9AC4-4B8D-A956-8906964A4FE7 Q38134139-044DD77B-AE0D-4456-B17D-059BA8E8F97C Q38142869-7E310ACE-0555-4DCE-A0BF-6BE8C84CC286 Q38153086-BA874F59-F9C8-48ED-AF41-EC10571058B6 Q38166665-BDC0420D-5E03-45DE-8C11-352AFACFA38A Q38172327-99DA7EF2-2F04-4D32-ABAF-6C3AA2261A35 Q38179303-2108F8BB-CFB8-4A78-8F88-C8D942E8876F Q38187365-9E777804-644C-45E6-9374-C93321253E2D Q38193333-FE10FABA-0DCD-491C-B530-B1EAB195FE07 Q38195220-C53CA9AB-C4EF-4039-BEE0-FD24FC12C6AF Q38232257-FDB6BEB7-5350-4D92-938B-D6A56FF2F45A Q38243007-D25637CE-DFE2-4F33-89C7-D67875C745DD Q38400848-B746691B-02D6-418E-9AE7-10009E93294A

P2860

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

http://www.wikidata.org/entity/Q39919495

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

@en

type

label

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

@en

prefLabel

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

@en

P1433

Q39919495-84E6E5C2-D8D9-4E67-B47C-1BF9BB89B566

P1476

Q39919495-CB7A8FAC-6F6F-4572-977B-A1687A62D1A0

P2093

Q39919495-19596B96-5DC4-41D6-97B3-EFF927F4D860

Q39919495-1AD3768D-3D00-4087-A4F8-18C431996845

Q39919495-617FE559-909A-411B-BCEA-2CBB9143A0D5

Q39919495-654F408A-F5A3-4319-A742-85603A84078A

Q39919495-6FD1BF40-658E-4F01-BEEB-6D6F4BD4B3C8

Q39919495-7B0A9F5B-2813-4CC7-86F9-0E5FEB2D6077

Q39919495-9E4C8296-609A-4560-B63A-CBAC352DB75E

Q39919495-BEFFD8CB-F19D-4156-B4ED-22D09858549E

Q39919495-DDCBFB9D-8F2D-45FB-AE51-22A882B6FD6F

Q39919495-DDE1F1AF-D376-4FD1-89A3-228A2ACB91C5

P304

Q39919495-CE1BFA58-65AF-468F-8F06-10AA6E9FCA3D

P31

Q39919495-9A948626-F649-4539-9754-0D63E79D7A42

P356

Q39919495-C8A9B613-D6BA-4D26-A8A4-50CFA603C18F

P407

Q39919495-3395BB3F-65A0-4AA5-BC6F-6C23C0283E25

P433

Q39919495-B91248AF-80B0-4F82-A6F8-151FDBAFAA71

P478

Q39919495-BC36AA7E-D173-472C-817E-A4F6EF174A5C

P577

Q39919495-1BB5A1E1-8C8E-4CF6-B8A9-0DB4F6013159

P5875

Q39919495-0C1F0855-6037-428D-9CCF-45DB9C68957D

P698

Q39919495-F787067B-726F-4954-B289-2780D8CB3D46

P356

JNUMED.109.067892

P1433

The Journal of Nuclear Medicine

P1476

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

@en

P2093

Ayelet Ben-Barak

http://www.w3.org/2001/XMLSchema#string

Eldad J Dann

http://www.w3.org/2001/XMLSchema#string

Irit Avivi

http://www.w3.org/2001/XMLSchema#string

Michal Weiler-Sagie

http://www.w3.org/2001/XMLSchema#string

Nissim Haim

http://www.w3.org/2001/XMLSchema#string

Olga Bushelev

http://www.w3.org/2001/XMLSchema#string

Ora Israel

http://www.w3.org/2001/XMLSchema#string

Rachel Bar-Shalom

http://www.w3.org/2001/XMLSchema#string

Ron Epelbaum

http://www.w3.org/2001/XMLSchema#string

Yehudit Ben-Arie

http://www.w3.org/2001/XMLSchema#string

P304

25-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.109.067892

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40686719

http://www.w3.org/2001/XMLSchema#string

P698

20009002

http://www.w3.org/2001/XMLSchema#string